First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background—The first trimester combined test (FTCT) is an effective screening tool to estimate the risk of fetal aneuploidy. It is obtained by the combination of maternal age, ultrasound fetal nuchal translucency (NT) measurement, and the maternal serum markers free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein A (PAPP-A). However, conflicting data have been reported about the association of FTCT, β-hCG, or PAPP-A with the subsequent diagnosis of gestational diabetes mellitus (GDM). Research design and methods—2410 consecutive singleton pregnant women were retrospectively enrolled in Calabria, Southern Italy. All participants underwent examinations for FTCT at 11–13 weeks (plus 6 days) of gestation, and screening for GDM at 16–18 and/or 24–28 weeks of gestation, in accordance with current Italian guidelines and the International Association Diabetes Pregnancy Study Groups (IADPSG) glycemic cut-offs. Data were examined by univariate and logistic regression analyses. Results—1814 (75.3%) pregnant women were normal glucose tolerant, while 596 (24.7%) were diagnosed with GDM. Spearman univariate analysis demonstrated a correlation between FTCT values and subsequent GDM diagnosis (ρ = 0.048, p = 0.018). The logistic regression analysis showed that women with a FTCT <1:10000 had a major GDM risk (p = 0.016), similar to women with a PAPP-A <1 multiple of the expected normal median (MoM, p = 0.014). Conversely, women with β-hCG ≥2.0 MoM had a reduced risk of GDM (p = 0.014). Conclusions—Our findings indicate that GDM susceptibility increases with fetal aneuploidy risk, and that FTCT and its related maternal serum parameters can be used as early predictors of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and represents a major risk factor for both adverse materno-fetal outcomes [1,2] and long-term maternal complications [3,4].”
BackgroundThe Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
HAPO Study Cooperative Research Group (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00092-9 · Cited by 401
Gestational Diabetes: Implications for Cardiovascular Health
Sullivan, S. D., Umans, J. G., & Ratner, R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-011-0238-3 · Cited by 143 · cited 1×
“Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and represents a major risk factor for both adverse materno-fetal outcomes [1,2] and long-term maternal complications [3,4].”
BackgroundGestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women
Capula, C., Chiefari, E., Vero, A., Arcidiacono, B., Iiritano, S., Puccio, L., Pullano, V., Foti, D. P., Brunetti, A., & Vero, R. (2013) · ISRN Endocrinology · doi:10.1155/2013/387495 · Cited by 43
Self-citationImpact of Seasonality on Gestational Diabetes Mellitus
Chiefari, E., Pastore, I., Puccio, L., Caroleo, P., Oliverio, R., Vero, A., Foti, D. P., Vero, R., & Brunetti, A. (2017) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530317666170808155526 · Cited by 38
Self-citationRitchie, K., Bradbury, I., Slattery, J., Wright, D., Iqbal, K., & Penney, G. (2005) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00560.x · Cited by 26 · cited 1×
“FTCT is routinely implemented in the process of prenatal screening for chromosomal abnormalities, with the advantages of non-invasiveness and cost-effectiveness [6,40].”
Background
Cited by
Gestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies
Paulo, M. S., Abdo, N. M., Bettencourt-Silva, R., & Al-Rifai, R. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.691033 · Cited by 181
Stern, C., Schwarz, S., Moser, G., Cvitic, S., Jantscher-Krenn, E., Gauster, M., & Hiden, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312722 · Cited by 114
The Rise and Fall of the Mediterranean Diet and Related Nutrients in Preventing Diabetes
Mirabelli, M., & Brunetti, A. (2022) · Nutrients · doi:10.3390/nu14020379 · Cited by 8
“Improvements in biomarkers of insulin resistance (IR) made the largest contribution to the long-term reduction in T2D risk mediated by the MedDiet, followed by changes in BMI, HDL measures, and inflammatory indices [8].”
BackgroundSelf-citation
Metadata
- Authors
- Visconti, F., Quaresima, P., Chiefari, E., Caroleo, P., Arcidiacono, B., Puccio, L., Mirabelli, M., Foti, D. P., Di Carlo, C., Vero, R., & Brunetti, A.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2019-09-28
- Volume
- 16
- Issue
- 19
- Pages
- 3654
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2976349107
- Cited by
- 44
- References
- 7
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.